Key Drivers and Restraints Shaping the Blood Plasma Derivatives Market
Immunoglobulins, often referred to as IVIG (Intravenous Immunoglobulin), are a key component of blood plasma derivatives. They are essentially a collection of antibodies from thousands of healthy plasma donors. When a patient's immune system is compromised or malfunctioning, IVIG can provide the antibodies needed to fight off infections. It's like a superhero team of antibodies, ready to defend the body from a wide range of pathogens. IVIG is a life-saving therapy for patients with primary immunodeficiency disorders, but its use has expanded significantly to treat a growing number of autoimmune and neurological conditions. By modulating the immune system, IVIG can help to control inflammation and prevent the body from attacking its own cells. The versatility and life-saving applications of IVIG are a major reason for its dominant position in the Blood Plasma Derivatives Market.